Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Revenues:
Product revenue, net	$ 180,133	$ 0	$ 0
Revenue from Contract with Customer, Product and Service [Extensible Enumeration]	Product [Member]
Operating expenses:
Cost of sales	$ 6,233	0	0
Research and development	236,718	272,350	245,441
Selling, general and administrative	435,057	108,146	48,130
Total operating expenses	678,008	380,496	293,571
Loss from operations	(497,875)	(380,496)	(293,571)
Interest income	46,654	19,578	2,185
Interest expense	(14,671)	(12,712)	(3,964)
Net loss	$ (465,892)	$ (373,630)	$ (295,350)
Net loss per common share:
Basic net loss per common share (in dollars per share)	$ (21.90)	$ (19.99)	$ (17.23)
Diluted net loss per common share (in dollars per share)	$ (21.90)	$ (19.99)	$ (17.23)
Basic weighted average number of common shares outstanding (in shares)	21,272,962	18,687,774	17,137,201
Diluted weighted average number of common shares outstanding (in shares)	21,272,962	18,687,774	17,137,201